Invenomic Capital Management L.P. 13F annual report

Invenomic Capital Management L.P. is an investment fund managing more than $1.88 trillion ran by Benjamin Deschaine. There are currently 166 companies in Mr. Deschaine’s portfolio. The largest investments include Viatris and SS&C Technologies Inc, together worth $111 billion.

Limited to 30 biggest holdings

$1.88 trillion Assets Under Management (AUM)

As of 7th February 2024, Invenomic Capital Management L.P.’s top holding is 5,812,880 shares of Viatris currently worth over $63 billion and making up 3.4% of the portfolio value.Relative to the number of outstanding shares of Viatris, Invenomic Capital Management L.P. owns more than approximately 0.1% of the company.In addition, the fund holds 786,755 shares of SS&C Technologies Inc worth $48.1 billion, whose value grew 6.6% in the past six months. The third-largest holding is Illumina Inc worth $48 billion and the next is Clarivate Plc worth $45.9 billion, with 4,958,488 shares owned.

Currently, Invenomic Capital Management L.P.'s portfolio is worth at least $1.88 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Invenomic Capital Management L.P.

The Invenomic Capital Management L.P. office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Benjamin Deschaine serves as the Chief Compliance Officer at Invenomic Capital Management L.P..